Christopher R Carroll

Address:

12531 Silversmine Dr, Houston, TX 77014

Phone:

2815837467

VIN:

2G1WC5E32C1152896

Make:

CHEVROLET

Model:

IMPALA

Year:

2012

US Patent:

20140066424, Mar 6, 2014

Filed:

Aug 23, 2013

Appl. No.:

13/974258

Inventors:

Maria Emilia DiFrancesco - Houston TX, US
Alessia Petrocchi - Houston TX, US
Christopher L. Carroll - Houston TX, US
Joe Marszalek - Houston TX, US
Barbara Czako - Houston TX, US
Ryan Johnson - Houston TX, US
Jay Theroff - Houston TX, US

Assignee:

Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer Center - Houston TX

International Classification:

C07D 413/04
C07D 417/14
A61K 31/454
A61K 45/06
A61K 31/496
C07D 413/14
C07D 417/04

US Classification:

51421018, 5142362, 51425403, 5142531, 514256, 514274, 514275, 514340, 514364, 514365, 514374, 544137, 544138, 544316, 544331, 544333, 544364, 544367, 544369, 5462691, 548124, 548131, 548205, 548235, 546176, 546194, 514314, 514318

Abstract:

The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.

US Patent:

48602280, Aug 22, 1989

Filed:

Feb 24, 1987

Appl. No.:

7/018148

Inventors:

Christopher J. Carroll - Streamwood IL

Assignee:

Motorola, Inc. - Schaumburg IL

International Classification:

G01B 700
G06F 700

US Classification:

364561

Abstract:

Disclosed is a technique for storing a count of incrementally increasing data exclusively in EEPROM using semaphores to avoid significant losses, as a result of power downs, greater than a single least significant bit in accuracy. The disclosed embodiment includes a first EEPROM register, comprised of 256 bits, for storing 256 incremental count increases, each bit is used to record an incremental count increase. A pair of 16 bit EEPROM registers is provided for incrementally storing updated count information in response to the first EEPROM register overflowing. Semaphores are provided for indicating whether or not the incrementally increasing count information has been at least partially stored in the pair of registers. Once an overflow from the first register is detected, the semaphores are checked to determine in what stage the update to the pair of registers was left (in case of power down). In response to the semaphore information, the overflow is stored in the pair of registers for a complete update of the count, and the semaphores are appropriately updated to so indicate.

US Patent:

20230008047, Jan 12, 2023

Filed:

May 21, 2021

Appl. No.:

17/327217

Inventors:

- Austin TX, US
Michael J. SOTH - Sugar Land TX, US
Philip JONES - Houston TX, US
Jason Bryant CROSS - Pearland TX, US
Christopher L. CARROLL - Houston TX, US
Timothy Joseph MCAFOOS - Pearland TX, US
Pijus Kumar MANDAL - Sugarland TX, US

International Classification:

A61K 31/5377
C07D 487/04
A61K 31/4985
C07D 495/04
C07D 471/04

Abstract:

The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases.

US Patent:

20210047311, Feb 18, 2021

Filed:

Sep 1, 2020

Appl. No.:

17/009428

Inventors:

- Austin TX, US
- South San Francisco CA, US
Christopher Lawrence CARROLL - Houston TX, US
Jason Bryant CROSS - Pearland TX, US
Suyambu Kesava Vijayan RAMASWAMY - Houston TX, US
Michael Garrett JOHNSON - San Francisco CA, US
Sarah LIVELY - San Carlos CA, US
David LAPOINTE - Oakland CA, US

International Classification:

C07D 413/14
C07D 413/04
C07D 411/14
A61K 45/06
C07D 471/04
A61P 35/00
C07D 417/14

Abstract:

The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.

US Patent:

20200407353, Dec 31, 2020

Filed:

Jul 10, 2020

Appl. No.:

16/925974

Inventors:

- Austin TX, US
Philip JONES - Houston TX, US
Timothy HEFFERNAN - Sugar Land TX, US
Matthew M. HAMILTON - Missouri City TX, US
Zhijun KANG - Richmond TX, US
Michael J. SOTH - Sugar Land TX, US
Jason P. BURKE - Houston TX, US
Kang LE - Sugar Land TX, US
Christopher Lawrence CARROLL - Houston TX, US
Wylie S. PALMER - Houston TX, US
Richard LEWIS - Missouri City TX, US
Timothy MCAFOOS - Pearland TX, US
Barbara CZAKO - Bellaire TX, US
Gang LIU - Sugar Land TX, US
Jay THEROFF - Manvel TX, US
Zachary HERRERA - El Cerrito CA, US
Anne YAU - Houston TX, US

International Classification:

C07D 417/14
A61K 31/4439
A61K 45/06
C07D 417/06
A61K 31/433
C07D 403/06
A61K 31/501
C07D 401/14
A61K 31/454
A61K 31/4192
C07D 405/14
C07D 403/14
A61K 31/444
C07D 493/08
A61K 31/497

Abstract:

Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I:Methods of inhibition GLS1 activity in a human or animal subject are also provided.

US Patent:

20200102296, Apr 2, 2020

Filed:

Jul 10, 2019

Appl. No.:

16/507851

Inventors:

- Austin TX, US
- South San Francisco CA, US
Christopher Lawrence CARROLL - Houston TX, US
Jason Bryant CROSS - Pearland TX, US
Suyambu Kesava Vijayan RAMASWAMY - Houston TX, US
Michael Garrett JOHNSON - San Francisco CA, US
Sarah LIVELY - San Carlos CA, US
David LAPOINTE - Oakland CA, US

International Classification:

C07D 413/14
C07D 413/04
C07D 411/14
A61K 45/06
C07D 471/04
A61P 35/00
C07D 417/14

Abstract:

The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.

US Patent:

20200048249, Feb 13, 2020

Filed:

Aug 9, 2019

Appl. No.:

16/536923

Inventors:

- Austin TX, US
Barbara CZAKO - Bellaire TX, US
Christopher L. CARROLL - Houston TX, US
Pijus MANDAL - Sugarland TX, US
Jason CROSS - Pearland TX, US

International Classification:

C07D 471/04
C07D 491/107
A61P 35/00

Abstract:

The present invention relates to compounds which are useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment of disease.

US Patent:

20190367536, Dec 5, 2019

Filed:

Aug 13, 2019

Appl. No.:

16/539693

Inventors:

- Austin TX, US
- South San Francisco CA, US
Christopher Lawrence CARROLL - Houston TX, US
Jason Bryant CROSS - Pearland TX, US
Michael Garrett JOHNSON - San Francisco CA, US
Sarah LIVELY - San Carlos CA, US

International Classification:

C07D 519/00
A61P 35/00

Abstract:

The present invention relates to tetrahydropyrido[4,3-d]pyrimidine based compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.